|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$2.09 |
$2.26 |
$2.09 |
$2.20 |
127.80K | 04/23/2024 |
$2.17 |
$2.34 |
$2.13 |
$2.26 |
101.60K | 04/24/2024 |
$2.29 |
$2.29 |
$2.22 |
$2.22 |
91.80K | 04/25/2024 |
$2.27 |
$2.29 |
$2.17 |
$2.27 |
97.80K | 04/26/2024 |
$2.30 |
$2.49 |
$2.27 |
$2.42 |
204.80K |
|
Regulus Therapeutics is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat diseases. Co.'s key product candidates are RG-012 and RGLS4326. RG-012 is an anti-miR targeting miR-21 for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. Co. has multiple programs in various stages of preclinical development including RGLS5579 as a clinical candidate in its glioblastoma multiforme program, its preclinical programs targeting the Hepatitis B virus and Non-Alcoholic Steatohepatitis program. | |
|
Regulus Therapeutics (RGLS) has the following price history information. Looking back at RGLS historical stock prices for the last five trading days, on April 22, 2024, RGLS opened at $2.09, traded as high as $2.26 and as low as $2.09, and closed at $2.20. Trading volume was a total of 127.80K shares. On April 23, 2024, RGLS opened at $2.17, traded as high as $2.34 and as low as $2.13, and closed at $2.26. Trading volume was a total of 101.60K shares. On April 24, 2024, RGLS opened at $2.29, traded as high as $2.29 and as low as $2.22, and closed at $2.22. Trading volume was a total of 91.80K shares. On April 25, 2024, RGLS opened at $2.27, traded as high as $2.29 and as low as $2.17, and closed at $2.27. Trading volume was a total of 97.80K shares. On April 26, 2024, RGLS opened at $2.30, traded as high as $2.49 and as low as $2.27, and closed at $2.42. Trading volume was a total of 204.80K shares.
RGLS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Regulus Therapeutics shares, starting with a $10,000 purchase of RGLS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$830.40 |
|
End price/share: |
$2.42 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.71% |
|
Average Annual Total Return: |
-44.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$29.16 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $2.20 | 04/23/2024 | $2.26 | 04/24/2024 | $2.22 | 04/25/2024 | $2.27 | 04/26/2024 | $2.42 |
|
|